Latest News

Kalbe Inaugurated Generic Medicine Factory

Health Minister inaugurated Generic Medicine Factory, producing 87 millions tablets/month

Kalbe Inaugurated Generic Medicine Factory

Cikarang, 28th February 2012 – Kalbe Group (Kalbe) today inaugurated the expansion of its generic medicine factory, PT Hexpharm Jaya in Cikarang. The inauguration was done by the Republic of Indonesia’s Health Minister, dr.Endang R. Sedyaningsih, MPH, Dr, PH. The factory which sits on a 13,295 m2 land took about Rp 150 billion in investment cost. In the future, this factory will have a production capacity of 87 million tablets monthly and absorb as much as 400 work forces.

“The development of this generic medicine factory is Kalbe’s effort to establish its long term commitment to be actively involved in enhancing people’s health through the provision of qualified yet affordable medicines, by meeting the needs for generic medicines in Indonesia,” said Irawati
Setiady, President Director for Kalbe Group. “To anticipate the rising demand in the future, Kalbe has realised that the production capacity of the Hexpharm Jaya factory in Cipanas has reached its maximum limit and therefore decided to build the extension of the Hexpharm Jaya factory in Cikarang.”
Kalbe sees that the rise in demands for generic medicines in the next few years is not merely related to the anticipation of government policy for National Social Guarantee System (SJSN) which will be implemented in 2014, but also to the people’s increased awareness of generic medicines.
This factory will produce quality generic medicines ready to meet the country’s needs. Among the products are tablets (2 line plain tablet, 3 line coated tablet) and dry syrup (1 line). Kalbe will use the brand Kalbe Generic for all generic medicines produced by Hexpharm Jaya factory.

About Hexpharm Jaya
PT Hexpharm Jaya (HJ) was founded in 1971, with factory site in Cipanas, Puncak, West Java. Until 2011, HJ has launched 30 medicine brands, 75 SKUs or Stock Keeping Units included in 11 therapy classes. Most of HJ’s products has passed the BA-BE (Bio Availability – Bio Equivalency) test, which proves HJ’s commitment in producing quality generic medicines. HJ has obtained the ISO 9001 Certificate since 2001, and in December 2011 has also obtained the certification on good medicines production and practices or CPOB (Cara Pembuatan Obat yang Baik) from Indonesia’s Food and Drugs Association or BPOM for its regular tablets and non-Antibiotic coated tablets; regular tablets and antibiotic coated tablets non beta lactam; oral dry suspension non-antibiotic; and oral dry suspension antibiotic non beta lactam.

About Kalbe
PT Kalbe Farma Tbk (“Kalbe”) was founded in 1966. It is one of the largest public listed pharmaceutical company in South East Asia. Kalbe has four main divisions which handle leading brands and vast portfolio - prescribed medicines business unit (Cefspan, Brainact, Broadced, etc); over the counter products (Woods, Promag, Mixagrip, Komix, Fatigon, etc); nutritionals (ChilKid, Prenagen, Diabetasol, etc); and distribution. Kalbe has more than twenty subsidiaries, nine production facilities with international standard, and hire more than 15,000 employees as well as 4,000 marketing and sales forces distributed across 65 branches all over Indonesia. Since 1991, Kalbe has been enlisted in the Jakarta Stock Exchange (IDX:KLBF).

8449 Rate this article:

Please login or register to post comments.